4.7 Article

Environmental risk assessment and bioaccumulation of pharmaceuticals in a large urbanized estuary

Journal

SCIENCE OF THE TOTAL ENVIRONMENT
Volume 783, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.scitotenv.2021.147021

Keywords

Emerging contaminants; Estuaries; Pharmaceutical uptake; Ecological traits; Multi-taxa

Funding

  1. Fundacao para a Ciencia e a Tecnologia (FCT) [UIDB/04292/2020, PTDC/MAR-EST/3048/2014]
  2. FCT [SFRH/BD/138376/2018]
  3. FCT researcher contract at FCUL [CEECIND/00511/2017, DL57/2016/CP1479/CT0024]
  4. Fundação para a Ciência e a Tecnologia [PTDC/MAR-EST/3048/2014, SFRH/BD/138376/2018] Funding Source: FCT

Ask authors/readers for more resources

The study found multiple pharmaceutical residues in surface waters of the Tejo estuary, with antibiotics and angiotensin II receptor blockers posing high ecological risks, while antidepressants, antiepileptics, anxiolytics and beta-blockers presented moderate risks. In biota, higher risk pharmaceuticals were detected in higher concentrations, indicating species-and compound-specific bioaccumulation.
We screened for the presence of 66 different pharmaceutical residues in surface waters and in multiple invertebrate and fish species of the Tejo estuary to produce an environmental risk assessment of individual pharmaceuticals and their mixtures, as well as evaluate the bioaccumulation of pharmaceuticals in one of Europe's largest estuarine systems. Sixteen pharmaceutical residues, from seven therapeutic classes, were detected in estuarine waters, with environmental mixture concentrations ranging from 42 to 1762 ng/L. Environmental risk assessment via the determination of risk quotients, demonstrated high ecological risk for the antibiotic amoxicillin and angiotensin II receptor blockers irbesartan and losartan. Moderate risk was estimated for antidepressants, antiepileptics, anxiolytics and beta-blockers, but the risk quotient of the accumulated mixture of compounds was over 380-fold higher than the no risk threshold, driven by antibiotics and angiotensin II receptor blockers. In biota, higher risk therapeutic groups were found in higher concentrations, with nine pharmaceutical residues detected, including six antibiotics and two neuroactive compounds, and maximum tissue concentrations up to 250 mu g/kg. Bioaccumulation was species-and compound-specific, with only two compounds found simultaneously in water and biota, likely a result of the complex dynamics and fate of pharmaceuticals in estuarine waters. Nonetheless, higher detection frequencies were observed in species living directly on or just above the substrate (i.e. benthic and demersal species), underpinning the importance of habitat use, as well the potential role of sediment and diet based routes for pharmaceutical uptake. Ultimately, results support urgent action on managing the impact of pharmaceuticals in coastal environments, striving for improved monitoring schemes tai-lored to the dynamic nature and ecological diversity of estuaries and coastal ecosystems. (c) 2021 Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available